Ferrante and Lacktman Quoted on Florida’s Cut of Telemedicine out of Medical Marijuana Law
June 15, 2017
mHealthIntelligence
Attorneys Nate Lacktman and TJ Ferrante were recently quoted in an mHealthIntelligence article, “Florida Cuts Telemedicine out of New Medical Marijuana Law,” covering, as they relate to the newly passed legislation, the requirements of telemedicine-based medical marijuana exams and the legal precautions for marijuana use, possession and production.
Lacktman and Ferrante explained, “even in states that allow telemedicine-based examinations for medical marijuana, providers should keep in mind that the examination for the condition for which medical marijuana is being recommended must be an appropriate prior examination and meet the standard of care.”
Lacktman continued by saying, “it is also important to note federal law still criminalizes the possession, use, and sale of marijuana. The new Florida law does not immunize violations of such federal law or any non-medical use, possession, or production of marijuana.”
Lacktman’s and Ferrante’s quotes were sourced from their recent Health Care Law Today blog post, which can be found here.
Lacktman and Ferrante explained, “even in states that allow telemedicine-based examinations for medical marijuana, providers should keep in mind that the examination for the condition for which medical marijuana is being recommended must be an appropriate prior examination and meet the standard of care.”
Lacktman continued by saying, “it is also important to note federal law still criminalizes the possession, use, and sale of marijuana. The new Florida law does not immunize violations of such federal law or any non-medical use, possession, or production of marijuana.”
Lacktman’s and Ferrante’s quotes were sourced from their recent Health Care Law Today blog post, which can be found here.
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.